These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19706985)

  • 1. Cystatin C in a high-risk combination.
    Iwanaga Y; Miyazaki S
    Circ J; 2009 Sep; 73(9):1593-4. PubMed ID: 19706985
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction.
    Ichimoto E; Jo K; Kobayashi Y; Inoue T; Nakamura Y; Kuroda N; Miyazaki A; Komuro I
    Circ J; 2009 Sep; 73(9):1669-73. PubMed ID: 19597298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatinine-or cystatin C-based equations to estimate glomerular filtration rate in acute myocardial infarction: a disparity in estimating renal function and in mortality risk prediction.
    Abu-Assi E; Raposeiras-Roubin S; Riveiro-Cruz A; Rodríguez-Girondo M; González-Cambeiro C; Alvarez-Alvarez B; Gestal-Romaní S; Pereira-López E; Cabanas-Grandío P; García-Acuña JM; Virgós-Lamela A; González-Juanatey JR
    Int J Cardiol; 2013 Oct; 168(4):4300-1. PubMed ID: 23714598
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cistatin C as a novel marker of renal function impairement and cardiovascular risk].
    Villeval'de SV; Gudgalis NI; Kobalava ZhD
    Kardiologiia; 2010; 50(6):78-82. PubMed ID: 20659033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of renal insufficiency on patients' outcomes in emergent angioplasty for acute myocardial infarction.
    Assali AR; Brosh D; Ben-Dor I; Solodky A; Fuchs S; Teplitsky I; Kornowski R
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):395-400. PubMed ID: 17195964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Çiçek G; Bozbay M; Açıkgöz SK; Altay S; Uğur M; Köroğlu B; Uyarel H
    Cardiol J; 2015; 22(1):101-7. PubMed ID: 24671903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
    Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
    J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.
    Hoke M; Amighi J; Mlekusch W; Schlager O; Exner M; Sabeti S; Dick P; Koppensteiner R; Minar E; Rumpold H; Wagner O; Schillinger M
    Stroke; 2010 Apr; 41(4):674-9. PubMed ID: 20150544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
    Rebholz CM; Grams ME; Matsushita K; Inker LA; Foster MC; Levey AS; Selvin E; Coresh J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):941-8. PubMed ID: 25825481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplementing creatinine-based estimates of risk in chronic kidney disease: is it time?
    Tonelli M; Manns B
    JAMA; 2011 Apr; 305(15):1593-5. PubMed ID: 21482745
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Valstar G; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P;
    Catheter Cardiovasc Interv; 2012 Jul; 80(1):18-26. PubMed ID: 21735520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C-based glomerular filtration rate associates more closely with mortality than creatinine-based or combined glomerular filtration rate equations in unselected patients.
    Helmersson-Karlqvist J; Ärnlöv J; Larsson A
    Eur J Prev Cardiol; 2016 Oct; 23(15):1649-57. PubMed ID: 27037092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C: efficacy as screening test for reduced glomerular filtration rate.
    Herget-Rosenthal S; Trabold S; Pietruck F; Holtmann M; Philipp T; Kribben A
    Am J Nephrol; 2000; 20(2):97-102. PubMed ID: 10773608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome.
    Ristiniemi N; Lund J; Tertti R; Christensson A; Ilva T; Porela P; Pulkki K; Pettersson K
    Clin Biochem; 2012 May; 45(7-8):535-40. PubMed ID: 22394460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C: influence of perfusion and myocardial injury on early (<24 h) renal function after pediatric cardiac surgery.
    Vassalos A; Young D; MacArthur K; Pollock J; Lyall F; Danton MH
    Paediatr Anaesth; 2011 Dec; 21(12):1185-91. PubMed ID: 21831111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C and contrast-induced nephropathy.
    Gambaro G; Graziani MS; Ribichini F
    Nephrol Dial Transplant; 2008 Dec; 23(12):4079; author reply 4079-80. PubMed ID: 18776210
    [No Abstract]   [Full Text] [Related]  

  • 20. Is serum cystatin C a better marker than serum creatinine for monitoring renal function in pediatric intensive care unit?
    Asilioglu N; Acikgoz Y; Paksu MS; Gunaydin M; Ozkaya O
    J Trop Pediatr; 2012 Dec; 58(6):429-34. PubMed ID: 22529319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.